Krystal Biotech (KRYS) Work In Process (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Work In Process data on file, last reported at $15.1 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 69.74% year-over-year to $15.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (up 69.74% YoY), and the FY2025 full-year result was $15.2 million, up 41.71% from the prior year.
• Work In Process fell to $15.1 million in Q1 2026, from $15.2 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $15.8 million in Q3 2025 to a low of $3.2 million in Q4 2023.
• A 4-year average of $10.2 million and a median of $9.8 million in 2024 frame the typical range for Work In Process.
• Across the five-year window, Work In Process surged 235.3% in 2024 and jumped 39.42% in 2025, its largest moves.
• Tracing KRYS's Work In Process over 4 years: stood at $3.2 million in 2023, then surged by 235.3% to $10.7 million in 2024, then soared by 41.71% to $15.2 million in 2025, then dropped by 0.72% to $15.1 million in 2026.
• Business Quant data shows KRYS's Work In Process at $15.1 million in Q1 2026, $15.2 million in Q4 2025, and $15.8 million in Q3 2025.